[DOHaD: long-term impact of perinatal diseases (IUGR and prematurity)]

Laurent Storme1, Dominique Luton2, Latifa Abdennebi-Najar3

  • 1EA4489, environnement périnatal et santé, faculté de médecine, université Lille 2, hôpital Jeanne de Flandre, CHRU de Lille, 1, rue Eugène Avinée, Lille, France.

Medecine Sciences : M/S
|February 7, 2016
PubMed

Insights

Premature birth, not intrauterine growth restriction, independently increases adult risk for chronic diseases like hypertension and neurodevelopmental issues. Prevention strategies for perinatal programming of noncommunicable diseases are discussed.

Area of Science:

  • Perinatal Medicine
  • Developmental Biology
  • Epidemiology

Background:

  • Early epidemiological studies linked low birth weight to adult chronic diseases without differentiating causes.
  • Low birth weight can stem from prematurity or intrauterine growth restriction (IUGR), or both.

Purpose of the Study:

  • To clarify the distinct roles of prematurity and IUGR in programming adult chronic diseases.
  • To explore the mechanisms and prevention of noncommunicable diseases programmed during the perinatal period.

Main Methods:

  • Review of epidemiological data and mechanistic studies on perinatal factors influencing adult health.
  • Analysis of distinct health outcomes associated with premature birth versus IUGR.

Main Results:

  • Prematurity is an independent risk factor for adult chronic diseases, including hypertension and neurodevelopmental/psychiatric issues.
  • Adults born prematurely do not exhibit an increased risk for metabolic syndrome (obesity, dyslipidemia) unlike those born with IUGR.
  • Mechanisms involve perinatal factors like infection, inflammation, placental insufficiency, and subsequent therapeutic strategies.

Conclusions:

  • Prematurity and IUGR have differential impacts on the long-term health of adults.
  • Understanding these distinct pathways is crucial for developing targeted prevention strategies against noncommunicable diseases programmed perinatally.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
19